Suppr超能文献

植物源细胞外囊泡:药物递送系统与天然生物活性化合物来源的协同组合。

Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds.

作者信息

Langellotto Mattia D, Rassu Giovanna, Serri Carla, Demartis Sara, Giunchedi Paolo, Gavini Elisabetta

机构信息

PhD Program in Biomedical Sciences - Neuroscience, Department of Biomedical Sciences, University of Sassari, Sassari, 07100, Italy.

Department of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/a, Sassari, 07100, Italy.

出版信息

Drug Deliv Transl Res. 2025 Mar;15(3):831-845. doi: 10.1007/s13346-024-01698-4. Epub 2024 Aug 28.

Abstract

Exosomes are extracellular nanovesicles secreted by all cell types and have been studied to understand and treat many human diseases. Exosomes are involved in numerous physiological and pathological processes, intercellular communication, and the transfer of substances. Over the years, several studies have explored mammalian-derived exosomes for therapeutic and diagnostic uses. Only recently have plant-derived extracellular vesicles (EVs) attracted attention for their ability to overcome many defects associated with using mammalian-derived extracellular vesicles, such as safety and scale-up issues. The ease of large-scale production, low toxicity, low immunogenicity, efficient cellular uptake, high biocompatibility, and high stability of these nanovesicles make them attractive for drug delivery systems. In addition, their native contents of proteins, miRNAs and secondary metabolites could be exploited for pharmaceutical applications in combination with other drugs. The present review intends to provide adequate tools for studying and developing drug delivery systems based on plant-derived EVs. Therefore, indications concerning extraction methods, characterisation, and drug loading will be offered. Their biological composition and content will also be reported. Finally, the current applications of these systems as nanocarriers for pharmacologically active substances will be shown.

摘要

外泌体是所有细胞类型分泌的细胞外纳米囊泡,人们对其进行了研究以了解和治疗多种人类疾病。外泌体参与众多生理和病理过程、细胞间通讯以及物质传递。多年来,多项研究探索了哺乳动物来源的外泌体在治疗和诊断方面的用途。直到最近,植物来源的细胞外囊泡(EVs)因其能够克服使用哺乳动物来源的细胞外囊泡所带来的许多缺陷(如安全性和扩大规模的问题)而受到关注。这些纳米囊泡易于大规模生产、低毒性、低免疫原性、高效的细胞摄取、高生物相容性和高稳定性,使其在药物递送系统方面具有吸引力。此外,它们天然含有的蛋白质、微小RNA(miRNAs)和次生代谢产物可与其他药物联合用于药物应用。本综述旨在为基于植物来源的EVs研究和开发药物递送系统提供充分的工具。因此,将介绍有关提取方法、表征和药物负载的内容。还将报道它们的生物组成和含量。最后,将展示这些系统作为药理活性物质纳米载体的当前应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/11782344/ecaccc6f61b1/13346_2024_1698_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验